Latest News about MOR
Recent news which mentions MOR
   Why Infinity Pharmaceuticals Shares Tumbled Around 38%; Here Are 79 Biggest Movers From Yesterday
   
  
  
  November 15, 2022
  From Benzinga
 
   One Alzheimer’s drug has failed, but investors are still betting on Biogen and Lilly treatments
   
  
  
  November 14, 2022
  From MarketWatch
 
   Roche's Alzheimer's Flop Trial Removes One Competitor, But Reimbursement Debate Lingers
   
  
  
  November 14, 2022
  From Benzinga
 
   Why Opiant Pharmaceuticals Shares Are Trading Higher By 115%? Here Are 53 Stocks Moving In Monday's Mid-Day Session
   
  
  
  November 14, 2022
  From Benzinga
 
   Stocks That Hit 52-Week Lows On Monday
   
  
  
  November 14, 2022
  From Benzinga
 
   12 Health Care Stocks Moving In Monday's Intraday Session
   
  
  
  November 14, 2022
  From Benzinga
 
   Hasbro, Ascendis Pharma, Coinbase Global And Some Other Big Stocks Moving Lower On Monday
   
  
  
  November 14, 2022
  From Benzinga
 
   Facebook Stalls Portal & Smartwatch Projects, Visa Breaks Debit Card Tie Up With FTX, $3B Bitcoin Withdrawn From Crypto Exchanges: Top Stories Monday, Nov. 14
   
  
  
  November 14, 2022
  From Benzinga
 
   12 Health Care Stocks Moving In Monday's Pre-Market Session
   
  
  
  November 14, 2022
  From Benzinga
 From InvestorPlace
 
   Roche's Another Alzheimer's Hopeful Flops In Phase 3 Program, Second Trial Setback Within Months
   
  
  
  November 14, 2022
  From Benzinga
 
   Nasdaq, S&P 500 Futures Pullback At Start Of New Trading Week As Rate Fears Return To Haunt; AMD, Tesla, Biogen, Eli Lilly, JD In Focus
   
  
  
  November 14, 2022
  From Benzinga
 
   Why MorphoSys Shares Are Trading Lower By Around 32%; Here Are 30 Stocks Moving Premarket
   
  
  
  November 14, 2022
  From Benzinga
 
   MorphoSys Highlights Preliminary Data From Tulmimetostat Study Across Broad Array of Advanced Tumors
   
  October 28, 2022
  Tickers 
   MOR
  
  
  From Benzinga
 
   MorphoSys' Monjuvi Shows Long-Term Durable Response In Blood Cancer Settings
   
  
  
  September 29, 2022
  From Benzinga
 
   Why NLS Pharmaceutics Shares Tumbled Over 66%; Here Are 68 Biggest Movers From Yesterday
   
  
  
  September 29, 2022
  From Benzinga
 
   These Stocks Are On The Radar After Biogen-Eisai's Surprising Alzheimer's Trial Win
   
  
  
  September 28, 2022
  From Benzinga
 
   Why Prothena Corporation Shares Are Trading Higher By 76%, Here Are 53 Stocks Moving In Wednesday's Mid-Day Session
   
  
  
  September 28, 2022
  From Benzinga
 From InvestorPlace
 From Benzinga
 
   Biogen, Eli Lilly And Some Other Big Stocks Moving Higher In Today's Pre-Market Session
   
  
  
  September 28, 2022
  From Benzinga
 
   21 Stocks Moving in Wednesday's Pre-Market Session
   
  
  
  June 22, 2022
  From Benzinga
 
   55 Stocks Moving In Wednesday's Mid-Day Session
   
  
  
  June 15, 2022
  From Benzinga
 From Benzinga
 
   24 Stocks Moving in Wednesday's Pre-Market Session
   
  
  
  June 15, 2022
  From Benzinga
 From Benzinga
 
   MorphoSys Stock Skyrockets On Entering Equity Participation and License Agreements With HIBio
   
  June 14, 2022
  Tickers 
   MOR
  
  
  From Benzinga
 From Benzinga
 
   Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  
  
 Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  © 2025 FinancialContent. All rights reserved.
 
